Alimera Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 31, 2023, and Provide Corporate Update

Rhea-AI Summary

Alimera Sciences (Nasdaq: ALIM) announces the release of its fourth quarter and full year 2022 financial results on March 31, 2023, prior to market opening. Following this, management will host a conference call at 9:00 AM ET to discuss results and corporate updates. Interested parties can pre-register or join via a live webcast.

Conference Call to be held Friday, March 31, at 9:00am Eastern Time

ATLANTA, March 24, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will report fourth quarter and full year 2022 financial results on Friday, March 31, 2023, before the market opens.

Management will host a conference call at 9:00 AM ET the same day, to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session.

Participants are asked to pre-register for the call.

Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-844-839-2190 (domestic) or 1-412-717-9583 (international). All callers should dial-in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.

The conference call will also be available through a live webcast, which is also available through the company’s website.

A webcast replay of the call will be available approximately one hour after the end of the call through July 1, 2023. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code 5931698. The telephonic replay will be available until April 14, 2023.

About Alimera Sciences, Inc.
Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.

For press inquiries:	For investor inquiries:
Jules Abraham	Scott Gordon
for Alimera Sciences	for Alimera Sciences
917-885-7378	scottg@coreir.com
julesa@coreir.com

                                
                                        
                                
                                       
       

FAQ

When will Alimera Sciences report its fourth quarter and full year 2022 financial results?

Alimera Sciences will report its financial results on March 31, 2023, before the market opens.

What time is the conference call for Alimera Sciences?

The conference call for Alimera Sciences is scheduled for 9:00 AM ET on March 31, 2023.

How can I participate in Alimera Sciences' conference call?

Participants can pre-register for the call or join via a live webcast available on the company's website.

Will there be a replay of the Alimera Sciences conference call?

Yes, a webcast replay will be available approximately one hour after the call until July 1, 2023.